IceCure Medical Ltd. (NASDAQ:ICCM – Free Report) – Research analysts at Brookline Capital Markets reduced their FY2030 earnings per share estimates for IceCure Medical in a report issued on Wednesday, August 12th. Brookline Capital Markets analyst K. Dolliver now expects that the company will earn $2.98 per share for the year, down from their prior […]

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities researchers at Brookline Capital Markets boosted their FY2029 earnings per share estimates for X4 Pharmaceuticals in a research report issued on Thursday, August 6th. Brookline Capital Markets analyst L. Cann now anticipates that the company will earn $0.99 per share for the year, up from their […]